Beyond the 5 A

Target Audience:

This activity is intended for physicians, nurses and other healthcare providers who provide or want to provide smoking cessation interventions to patients.

Program Overview:

Physicians, nurses, and other healthcare providers who provide or want to provide smoking cessation interventions to patients are encouraged to participate in this online CME/CE activity that summarizes material presented at the Beyond the 5A’s Conference. Beyond the 5 A’s was a meeting held November 13-15, 2013 that brought together public health tobacco cessation experts, systems decision-makers, healthcare providers and researchers to translate recent advances in both evidence and practice into action that will improve the frequency and effectiveness of smoking cessation interventions delivered by healthcare professionals. 

 

Accreditation:

National Jewish Health is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

National Jewish Health designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Faculty Listing:

Linda A. Bailey, JD, MHS
President and CEO
North American Quitline Consortium
 
Steven A. Schroeder, MD
Distinguished Professor of Health and Health Care, Department of Medicine
Director, Smoking Cessation Leadership Center
University of California, San Francisco 
 
Tamatha Thomas-Haase, MPA
Manager, Training & Program Services
North American Quitline Consortium
 
David Tinkelman, MD
Medical Director, Health Initiatives
National Jewish Health

Subjects:

  • Respiratory
  • Patient Adherence
  • Allergy
  • Cardiology
  • Pulmonology
  • Smoking Cessation
  • Preventable Disease

Objectives:

  • Apply various strategies for strengthening cessation interventions with patients.
  • Identify the changing demographics of tobacco users and approaches for cessation for different populations of tobacco users.
  • Understand quitline services and how to incorporate them into your cessation efforts with patients.
  • Identify barriers and facilitators to cessation treatment.

Financial Disclosure:

In accordance with the Accreditation Council for Continuing Medical Education, National Jewish Health requires that all program faculty, content developers, CME approval committee, and medical writers in a position to control the content of this activity are expected to disclose any or not significant financial interest or other relationship with any proprietary entity producing health care goods or services, with the exemption of non-profit or governmental organizations and non-health care related companies. Our goal is to ensure that there is no compromise of the ethical relationship that exists between those in a position to control the content of the activity and those attending the activity and their respective professional duties.
Significant financial interest is defined as receiving, or in the past twelve months having received, a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., Stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received or expected.
All CME Educational Activities sponsored by National Jewish Health are reviewed by our faculty CME committee to ensure a balanced and evidence-based presentation. Any potential conflict of interest among program faculty has been identified and resolved according to ACCME guidelines.

Key
A - Advisory Board C - Consultant
I - Investigator O - Other SP - Speaker

Disclosures

Andrea Harshman, MHA, CCMEP, CMP
Director, Office of Professional Education
National Jewish Health
Ms. Harshman has no significant financial interests to report.

Linda A. Bailey, JD, MHS
O – Pfizer and GlaxoSmithKline
I – Pfizer

Tamatha Thomas-Haase, MPA
Ms. Thomas-Haase has no significant financial interests to report.

David Tinkelman, MD
Dr. Tinkelman has no significant financial interests to report.

Esther Langmack, MD
Medical Director
National Jewish Health
Dr. Langmack has no significant financial interests to report.